Determinants of COVID-19 vaccine acceptance in the US
By A. Malik, S. McFadden, J. Elharake, S. Omer. medRxiv, 2020
1,297 citations recorded by the source corpus.
Background:The COVID-19 pandemic continues to adversely affect the U.S., which leads globally in total cases and deaths. As COVID-19 vaccines are under development, public health officials and policymakers need to create strategic vaccine-acceptance messaging to effectively control the pandemic and prevent thousands of additional deaths. Methods: Using an online platform, we surveyed the U.S. adult population in May 2020 to understand risk perceptions about the COVID-19 pandemic, acceptance of a COVID-19 vaccine, and trust in sources of information. These factors were compared across basic demographics. Findings: Of the 672 participants surveyed, 450 (67%) said they would accept a COVID-19 vaccine if it is recommended for them. Males (72%), older adults ([≥]55 years; 78%), Asians (81%), and college and/or graduate degree holders (75%) were more likely to accept the vaccine. When comparing reported influenza vaccine uptake to reported acceptance of the COVID-19 vaccine: 1) participants who did not complete high school had a very low influenza vaccine uptake (10%), while 60% of the same group said they would accept the COVID-19 vaccine; 2) unemployed participants reported lower influenza uptake and lower COVID-19 vaccine acceptance when compared to those employed or retired; and, 3) black Americans reported lower influenza vaccine uptake and lower COVID-19 vaccine acceptance than nearly all other racial groups. Lastly, we identified geographic differences with Department of Health and Human Services regions 2 (New York) and 5 (Chicago) reporting less than 50 percent COVID-19 vaccine acceptance. Interpretation: Although our study found a 67% acceptance of a COVID-19 vaccine, there were noticeable demographic and geographical disparities in vaccine acceptance. Before a COVID-19 vaccine is introduced to the U.S., public health officials and policymakers must prioritize effective COVID-19 vaccine-acceptance messaging for all Americans, especially those who are most vulnerable.
Subfields: Clinical Psychology, Health, Infectious Diseases
View Paper: https://www.semanticscholar.org/paper/3081cb514969570bbfb5d2e74de9660154d24047
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Health
In Infectious Diseases
Citations in the corpus
- COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates (2021, background): “Malik et al [66] US May, 2020 Agree/strongly agree 672 General population 67.”
- Science Skepticism Across 24 Countries (2021, neutral): “Indeed, these results may be particularly informative when the aim is to understand how trust in science and compliance with its recommendations vary across individuals and countries, for example, during a global pandemic like COVID-19.”
- Confidence and Receptivity for COVID-19 Vaccines: A Rapid Systematic Review (2020, background): “One study found Blacks were 40% more likely than Whites to reject due to lack of trust in vaccine safety, efficacy, and resources [42].”